Citation
Phase 1 evaluation of APN401, an autologous CBL-B-silenced PBMC therapy, in advanced solid tumors. // Molecular Therapy: Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S295032992600233X?dgcid=rss_sd_all
Phase 1 evaluation of APN401, an autologous CBL-B-silenced PBMC therapy, in advanced solid tumors. Molecular Therapy: Oncology. https://www.sciencedirect.com/science/article/pii/S295032992600233X?dgcid=rss_sd_all
“Phase 1 evaluation of APN401, an autologous CBL-B-silenced PBMC therapy, in advanced solid tumors.” Molecular Therapy: Oncology.
@article{article59171,
title = {Phase 1 evaluation of APN401, an autologous CBL-B-silenced PBMC therapy, in advanced solid tumors},
journal = {Molecular Therapy: Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S295032992600233X?dgcid=rss_sd_all}
}